Aldeyra Therapeutics (ALDX) SEC Filings & 10K Form

$4.20
+0.26 (+6.60%)
(As of 05/1/2024 ET)

Recent Aldeyra Therapeutics SEC Filings

DateFilerForm TypeView
04/25/2024
6:01 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
11:15 PM
Aldeyra Therapeutics (Filer)
Form EFFECT
04/22/2024
3:11 PM
Aldeyra Therapeutics (Filer)
Form DEF 14A
04/22/2024
3:13 PM
Aldeyra Therapeutics (Filer)
Form DEFA14A
04/22/2024
3:18 PM
Aldeyra Therapeutics (Filer)
Form ARS
04/08/2024
4:32 PM
Aldeyra Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
4:22 PM
Aldeyra Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
6:01 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
7:01 PM
Aldeyra Therapeutics (Issuer)
Brady Todd C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:04 PM
Aldeyra Therapeutics (Issuer)
Machatha Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:07 PM
Aldeyra Therapeutics (Issuer)
Greenberg Bruce (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:11 PM
Aldeyra Therapeutics (Subject)
Greenberg Bruce (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
7:43 PM
Aldeyra Therapeutics (Subject)
Machatha Stephen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
6:12 PM
Aldeyra Therapeutics (Subject)
Brady Todd C (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2024
3:48 PM
Aldeyra Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/07/2024
3:40 PM
Aldeyra Therapeutics (Filer)
Form S-8 POS
01/04/2024
6:00 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2023
6:05 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2023
6:16 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
3:43 PM
Aldeyra Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/01/2023
6:09 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2023
5:07 PM
Aldeyra Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G/A
10/18/2023
4:15 PM
Aldeyra Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2023
7:00 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
2:22 PM
Aldeyra Therapeutics (Subject)
Knoll Capital Management, LLC (Filed by)
Form SC 13G
09/11/2023
4:42 PM
Aldeyra Therapeutics (Issuer)
Brady Todd C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
3:31 PM
Aldeyra Therapeutics (Issuer)
Phillips Gary M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2023
3:13 PM
Aldeyra Therapeutics (Issuer)
Walker Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:42 PM
Aldeyra Therapeutics (Issuer)
Miller-Rich Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:43 PM
Aldeyra Therapeutics (Issuer)
Phillips Gary M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:46 PM
Aldeyra Therapeutics (Issuer)
JOYCE MARTIN JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:30 PM
Aldeyra Therapeutics (Issuer)
Walker Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:32 PM
Aldeyra Therapeutics (Issuer)
DOUGLAS RICHARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:34 PM
Aldeyra Therapeutics (Issuer)
Bronstein Ben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
3:07 PM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/29/2023
3:23 PM
Aldeyra Therapeutics (Issuer)
Bronstein Ben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2023
6:01 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2023
6:01 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2023
3:25 PM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2023
6:01 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2023
6:05 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Have You Seen Elon’s New A.I. Device? (Picture Inside) (Ad)

A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...

This strange new device to protect us against that A.I. threat...
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ALDX) was last updated on 5/2/2024 by MarketBeat.com Staff

From Our Partners